| neutral lipid metabolic process | GO:0006638 | 57 | 0.754 | |
| negative regulation of execution phase of apoptosis | GO:1900118 | 4 | 0.669 | |
| positive regulation of sequestering of triglyceride | GO:0010890 | 4 | 0.622 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.582 | |
| anion transport | GO:0006820 | 177 | 0.526 | Mouse |
| ribonucleoside bisphosphate metabolic process | GO:0033875 | 9 | 0.520 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.512 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.494 | |
| regulation of sequestering of triglyceride | GO:0010889 | 6 | 0.475 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.468 | |
| acylglycerol catabolic process | GO:0046464 | 11 | 0.431 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.430 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.428 | |
| transmembrane transport | GO:0055085 | 412 | 0.421 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.328 | |
| cation transport | GO:0006812 | 399 | 0.324 | |
| sodium ion export from cell | GO:0036376 | 1 | 0.324 | |
| regulation of fatty acid metabolic process | GO:0019217 | 28 | 0.318 | |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.310 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.272 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.254 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.243 | |
| hexose metabolic process | GO:0019318 | 98 | 0.237 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.230 | |
| striated muscle contraction | GO:0006941 | 45 | 0.224 | |
| cofactor metabolic process | GO:0051186 | 80 | 0.223 | |
| regulation of fatty acid oxidation | GO:0046320 | 10 | 0.214 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.210 | |
| fat cell differentiation | GO:0045444 | 160 | 0.205 | |
| organic anion transport | GO:0015711 | 137 | 0.195 | Mouse |
| lipid modification | GO:0030258 | 65 | 0.192 | |
| oxidation reduction process | GO:0055114 | 342 | 0.182 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.181 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.169 | |
| muscle system process | GO:0003012 | 141 | 0.168 | |
| locomotory behavior | GO:0007626 | 195 | 0.166 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.165 | |
| regulation of system process | GO:0044057 | 200 | 0.165 | |
| brown fat cell differentiation | GO:0050873 | 36 | 0.163 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.157 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.156 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.154 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.148 | |
| cellular lipid catabolic process | GO:0044242 | 52 | 0.145 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.143 | |
| negative regulation of lipid metabolic process | GO:0045833 | 30 | 0.143 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.137 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.136 | |
| glucose metabolic process | GO:0006006 | 92 | 0.135 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.134 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.132 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.131 | |
| cation homeostasis | GO:0055080 | 212 | 0.127 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.123 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.123 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.121 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.119 | |
| spermatogenesis | GO:0007283 | 284 | 0.118 | |
| positive regulation of lipid storage | GO:0010884 | 10 | 0.118 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.117 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.115 | |
| negative regulation of lipid catabolic process | GO:0050995 | 6 | 0.113 | |
| lipid catabolic process | GO:0016042 | 69 | 0.111 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.111 | |
| rhythmic process | GO:0048511 | 174 | 0.109 | |
| sodium ion transport | GO:0006814 | 73 | 0.109 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.108 | |
| regulation of lipid biosynthetic process | GO:0046890 | 54 | 0.108 | |
| lipid localization | GO:0010876 | 126 | 0.108 | Mouse |
| heterocycle catabolic process | GO:0046700 | 280 | 0.106 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.105 | |
| myosin filament organization | GO:0031033 | 3 | 0.104 | |
| sodium ion transmembrane transport | GO:0035725 | 49 | 0.103 | |
| cellular homeostasis | GO:0019725 | 240 | 0.101 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.099 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.098 | |
| muscle contraction | GO:0006936 | 101 | 0.096 | |
| sequestering of triglyceride | GO:0030730 | 6 | 0.096 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.095 | |
| response to peptide hormone | GO:0043434 | 127 | 0.094 | |
| lipid oxidation | GO:0034440 | 29 | 0.093 | |
| phosphatidylethanolamine biosynthetic process | GO:0006646 | 2 | 0.092 | |
| organic acid transport | GO:0015849 | 101 | 0.088 | Mouse |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.086 | |
| acyl coa biosynthetic process | GO:0071616 | 7 | 0.085 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.085 | |
| maintenance of location | GO:0051235 | 89 | 0.083 | Mouse |
| regulation of skeletal muscle contraction | GO:0014819 | 3 | 0.082 | |
| fatty acid catabolic process | GO:0009062 | 25 | 0.079 | |
| amine metabolic process | GO:0009308 | 45 | 0.078 | |
| fatty acyl coa metabolic process | GO:0035337 | 4 | 0.078 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.074 | |
| action potential | GO:0001508 | 78 | 0.073 | |
| blood circulation | GO:0008015 | 195 | 0.072 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.072 | |
| negative regulation of sodium ion transmembrane transporter activity | GO:2000650 | 1 | 0.071 | |
| circulatory system process | GO:0003013 | 197 | 0.070 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.069 | |
| regulation of ion transport | GO:0043269 | 215 | 0.069 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.068 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.068 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.068 | |
| pyruvate metabolic process | GO:0006090 | 28 | 0.067 | |
| adult behavior | GO:0030534 | 135 | 0.067 | |
| fatty acid transmembrane transport | GO:1902001 | 1 | 0.067 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.066 | |
| nucleoside bisphosphate metabolic process | GO:0033865 | 9 | 0.066 | |
| glycerolipid catabolic process | GO:0046503 | 16 | 0.066 | |
| male gamete generation | GO:0048232 | 285 | 0.066 | |
| circadian regulation of gene expression | GO:0032922 | 48 | 0.065 | |
| germ line stem cell division | GO:0042078 | 2 | 0.065 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.064 | |
| metanephric glomerular epithelial cell differentiation | GO:0072312 | 2 | 0.064 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.063 | |
| regulation of protein processing | GO:0070613 | 96 | 0.061 | |
| regulation of striated muscle contraction | GO:0006942 | 25 | 0.060 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.060 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.059 | |
| white fat cell differentiation | GO:0050872 | 15 | 0.059 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.059 | |
| regulation of cardiac muscle contraction | GO:0055117 | 21 | 0.059 | |
| synaptic transmission | GO:0007268 | 329 | 0.059 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.058 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.058 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.058 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.058 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.056 | |
| coenzyme metabolic process | GO:0006732 | 52 | 0.056 | |
| sodium ion export | GO:0071436 | 2 | 0.055 | |
| cholesterol storage | GO:0010878 | 4 | 0.054 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.054 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.054 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.054 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.054 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.054 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.053 | |
| regulation of circadian sleep wake cycle sleep | GO:0045187 | 3 | 0.053 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.053 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.053 | |
| neuron death | GO:0070997 | 154 | 0.052 | |
| ventricular cardiac muscle cell action potential | GO:0086005 | 4 | 0.052 | |
| protein import into nucleus | GO:0006606 | 95 | 0.052 | |
| response to insulin | GO:0032868 | 100 | 0.052 | |
| mapk cascade | GO:0000165 | 281 | 0.052 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.051 | |
| acylglycerol biosynthetic process | GO:0046463 | 18 | 0.050 | |
| lipid homeostasis | GO:0055088 | 63 | 0.050 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.050 | |
| regulation of triglyceride metabolic process | GO:0090207 | 17 | 0.050 | |
| regulation of phospholipid biosynthetic process | GO:0071071 | 3 | 0.050 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.050 | |
| response to oxidative stress | GO:0006979 | 123 | 0.049 | |
| regulation of lipid catabolic process | GO:0050994 | 15 | 0.049 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.048 | |
| polysaccharide metabolic process | GO:0005976 | 39 | 0.048 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.048 | |
| regulation of sodium ion transport | GO:0002028 | 29 | 0.047 | |
| circadian rhythm | GO:0007623 | 114 | 0.047 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.047 | |
| organic acid catabolic process | GO:0016054 | 51 | 0.046 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.046 | |
| very long chain fatty acid catabolic process | GO:0042760 | 2 | 0.046 | |
| diacylglycerol metabolic process | GO:0046339 | 6 | 0.046 | |
| negative regulation of cellular response to growth factor stimulus | GO:0090288 | 46 | 0.046 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.045 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.045 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.045 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.045 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.044 | |
| coenzyme biosynthetic process | GO:0009108 | 23 | 0.044 | |
| cholesterol homeostasis | GO:0042632 | 44 | 0.044 | |
| urogenital system development | GO:0001655 | 261 | 0.043 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.043 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.043 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.043 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.043 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.043 | |
| potassium ion transmembrane transport | GO:0071805 | 43 | 0.042 | |
| female sex differentiation | GO:0046660 | 84 | 0.042 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.042 | |
| positive regulation of fatty acid oxidation | GO:0046321 | 4 | 0.041 | |
| fatty acid oxidation | GO:0019395 | 28 | 0.041 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.041 | |
| fatty acid biosynthetic process | GO:0006633 | 41 | 0.041 | |
| positive regulation of glycolytic process | GO:0045821 | 4 | 0.041 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.041 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.041 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.040 | |
| response to radiation | GO:0009314 | 165 | 0.040 | |
| triglyceride biosynthetic process | GO:0019432 | 17 | 0.040 | |
| regulation of lipoprotein lipase activity | GO:0051004 | 4 | 0.040 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.039 | |
| response to drug | GO:0042493 | 75 | 0.039 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.039 | |
| monosaccharide biosynthetic process | GO:0046364 | 44 | 0.039 | |
| phosphatidylethanolamine metabolic process | GO:0046337 | 2 | 0.039 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.039 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.039 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.039 | |
| negative regulation of transforming growth factor beta receptor signaling pathway | GO:0030512 | 26 | 0.039 | |
| cell division | GO:0051301 | 120 | 0.038 | |
| calcium ion transport | GO:0006816 | 159 | 0.038 | |
| calcium ion transmembrane transport | GO:0070588 | 85 | 0.038 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.038 | |
| positive regulation of voltage gated calcium channel activity | GO:1901387 | 2 | 0.038 | |
| neuromuscular process | GO:0050905 | 99 | 0.037 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.037 | |
| drug metabolic process | GO:0017144 | 4 | 0.037 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.037 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.037 | |
| energy coupled proton transmembrane transport against electrochemical gradient | GO:0015988 | 3 | 0.036 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.036 | |
| monocarboxylic acid catabolic process | GO:0072329 | 27 | 0.036 | |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.036 | |
| response to oxygen radical | GO:0000305 | 16 | 0.036 | |
| regulation of neuron death | GO:1901214 | 134 | 0.036 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.035 | |
| planar cell polarity pathway involved in ventricular septum morphogenesis | GO:0061348 | 2 | 0.035 | |
| regulation of lipid storage | GO:0010883 | 20 | 0.035 | |
| heart contraction | GO:0060047 | 93 | 0.035 | |
| response to peptide | GO:1901652 | 136 | 0.035 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.034 | |
| respiratory tube development | GO:0030323 | 167 | 0.034 | |
| response to hypoxia | GO:0001666 | 58 | 0.034 | |
| bronchiole morphogenesis | GO:0060436 | 1 | 0.034 | |
| protein oligomerization | GO:0051259 | 67 | 0.033 | |
| regulation of transporter activity | GO:0032409 | 57 | 0.033 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.033 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.033 | |
| dna catabolic process endonucleolytic | GO:0000737 | 15 | 0.033 | |
| acylglycerol homeostasis | GO:0055090 | 16 | 0.033 | |
| neutral lipid biosynthetic process | GO:0046460 | 18 | 0.033 | |
| epithelial cell development | GO:0002064 | 159 | 0.033 | |
| negative regulation of sodium ion transmembrane transport | GO:1902306 | 1 | 0.033 | |
| l glutamate import into cell | GO:1990123 | 3 | 0.033 | |
| learning or memory | GO:0007611 | 148 | 0.032 | |
| regulation of carbohydrate biosynthetic process | GO:0043255 | 40 | 0.032 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.032 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 54 | 0.032 | |
| cell cell signaling involved in lung development | GO:0060495 | 1 | 0.032 | |
| fat soluble vitamin biosynthetic process | GO:0042362 | 4 | 0.032 | |
| regulation of fatty acid biosynthetic process | GO:0042304 | 12 | 0.032 | |
| sterol homeostasis | GO:0055092 | 45 | 0.031 | |
| lipid transport | GO:0006869 | 98 | 0.031 | Mouse |
| response to oxygen levels | GO:0070482 | 62 | 0.031 | |
| tubulin complex biogenesis | GO:0072668 | 2 | 0.031 | |
| cellular modified amino acid biosynthetic process | GO:0042398 | 12 | 0.031 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.031 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.031 | |
| renal sodium ion transport | GO:0003096 | 2 | 0.031 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.031 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.031 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 49 | 0.031 | |
| response to superoxide | GO:0000303 | 16 | 0.031 | |
| positive regulation of growth | GO:0045927 | 104 | 0.031 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.031 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.030 | |
| regulation of transmission of nerve impulse | GO:0051969 | 1 | 0.030 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.030 | |
| regulation of sodium ion transmembrane transporter activity | GO:2000649 | 9 | 0.030 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.030 | |
| positive regulation of fatty acid biosynthetic process | GO:0045723 | 3 | 0.030 | |
| regulation of circadian rhythm | GO:0042752 | 58 | 0.030 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.030 | |
| positive regulation of cyclic nucleotide biosynthetic process | GO:0030804 | 24 | 0.030 | |
| regulation of muscle contraction | GO:0006937 | 49 | 0.030 | |
| membrane organization | GO:0061024 | 245 | 0.029 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.029 | |
| plasma membrane long chain fatty acid transport | GO:0015911 | 1 | 0.029 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.029 | |
| renal system process | GO:0003014 | 48 | 0.029 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.029 | |
| multicellular organism growth | GO:0035264 | 161 | 0.029 | |
| thioester biosynthetic process | GO:0035384 | 7 | 0.029 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.029 | |
| hydrogen transport | GO:0006818 | 35 | 0.029 | |
| cardiac muscle cell contraction | GO:0086003 | 7 | 0.028 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.028 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.028 | |
| myosin filament assembly | GO:0031034 | 2 | 0.028 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.028 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.028 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.027 | |
| smooth muscle contraction | GO:0006939 | 44 | 0.027 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.027 | |
| protein catabolic process | GO:0030163 | 221 | 0.027 | |
| receptor biosynthetic process | GO:0032800 | 3 | 0.027 | |
| regulation of voltage gated calcium channel activity | GO:1901385 | 4 | 0.027 | |
| hormone metabolic process | GO:0042445 | 86 | 0.027 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.027 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.027 | |
| regulation of calcium ion transmembrane transporter activity | GO:1901019 | 20 | 0.027 | |
| mitochondrion organization | GO:0007005 | 134 | 0.027 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.027 | |
| gluconeogenesis | GO:0006094 | 39 | 0.026 | |
| short chain fatty acid catabolic process | GO:0019626 | 2 | 0.026 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.026 | |
| acetylcholine transport | GO:0015870 | 2 | 0.026 | |
| drug catabolic process | GO:0042737 | 2 | 0.026 | |
| kidney development | GO:0001822 | 213 | 0.026 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.026 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.026 | |
| oxygen homeostasis | GO:0032364 | 2 | 0.026 | |
| cellular response to cadmium ion | GO:0071276 | 3 | 0.026 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.026 | |
| hexose biosynthetic process | GO:0019319 | 39 | 0.026 | |
| forebrain development | GO:0030900 | 302 | 0.026 | |
| cellular potassium ion transport | GO:0071804 | 43 | 0.025 | |
| bile acid metabolic process | GO:0008206 | 17 | 0.025 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.025 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.025 | |
| regulation of calcium ion transport | GO:0051924 | 69 | 0.025 | |
| regulation of steroid metabolic process | GO:0019218 | 39 | 0.025 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.025 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.025 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.025 | |
| regulation of inward rectifier potassium channel activity | GO:1901979 | 1 | 0.024 | |
| heart process | GO:0003015 | 94 | 0.024 | |
| multicellular organismal aging | GO:0010259 | 24 | 0.024 | |
| dna metabolic process | GO:0006259 | 303 | 0.024 | |
| regulation of neurotransmitter levels | GO:0001505 | 87 | 0.024 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.024 | |
| cellular component disassembly involved in execution phase of apoptosis | GO:0006921 | 9 | 0.024 | |
| amide transport | GO:0042886 | 138 | 0.024 | |
| unsaturated fatty acid biosynthetic process | GO:0006636 | 15 | 0.024 | |
| cardiac muscle fiber development | GO:0048739 | 4 | 0.024 | |
| regulation of sodium ion transmembrane transport | GO:1902305 | 9 | 0.024 | |
| regulation of white fat cell proliferation | GO:0070350 | 2 | 0.024 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.023 | Mouse |
| multicellular organismal metabolic process | GO:0044236 | 28 | 0.023 | |
| positive regulation of fatty acid beta oxidation | GO:0032000 | 1 | 0.023 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.023 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.023 | |
| cellular amino acid biosynthetic process | GO:0008652 | 22 | 0.023 | |
| positive regulation of high voltage gated calcium channel activity | GO:1901843 | 1 | 0.023 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.023 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.023 | |
| associative learning | GO:0008306 | 61 | 0.023 | |
| wnt signaling pathway involved in forebrain neuroblast division | GO:0021874 | 2 | 0.023 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.023 | |
| regulation of synaptic plasticity | GO:0048167 | 87 | 0.023 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.023 | |
| regulation of fatty acid beta oxidation | GO:0031998 | 1 | 0.022 | |
| adiponectin activated signaling pathway | GO:0033211 | 4 | 0.022 | |
| neuronal action potential | GO:0019228 | 54 | 0.022 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.022 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.022 | |
| arachidonic acid metabolite production involved in inflammatory response | GO:0002538 | 2 | 0.022 | |
| directional locomotion | GO:0033058 | 3 | 0.022 | |
| regulation of camp metabolic process | GO:0030814 | 30 | 0.022 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.022 | |
| leukotriene production involved in inflammatory response | GO:0002540 | 2 | 0.022 | |
| elastic fiber assembly | GO:0048251 | 4 | 0.022 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.022 | |
| alcohol biosynthetic process | GO:0046165 | 43 | 0.022 | |
| cerebellum development | GO:0021549 | 77 | 0.022 | |
| fatty acid beta oxidation | GO:0006635 | 16 | 0.022 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.022 | |
| regulation of circadian sleep wake cycle | GO:0042749 | 3 | 0.022 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.021 | |
| proton transport | GO:0015992 | 35 | 0.021 | |
| negative regulation of fatty acid metabolic process | GO:0045922 | 10 | 0.021 | |
| triglyceride homeostasis | GO:0070328 | 15 | 0.021 | |
| regulation of high voltage gated calcium channel activity | GO:1901841 | 2 | 0.021 | |
| intrinsic apoptotic signaling pathway in response to oxidative stress | GO:0008631 | 19 | 0.021 | |
| lipid storage | GO:0019915 | 36 | 0.021 | Mouse |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.021 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.021 | |
| harderian gland development | GO:0070384 | 2 | 0.021 | |
| corticotropin hormone secreting cell differentiation | GO:0060128 | 3 | 0.021 | |
| regulation of stress activated mapk cascade | GO:0032872 | 69 | 0.021 | |
| positive regulation of striated muscle contraction | GO:0045989 | 3 | 0.021 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.021 | |
| negative regulation of transmembrane transport | GO:0034763 | 15 | 0.020 | |
| cellular response to peptide | GO:1901653 | 92 | 0.020 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.020 | |
| apoptotic process involved in morphogenesis | GO:0060561 | 25 | 0.020 | |
| positive regulation of cellular carbohydrate metabolic process | GO:0010676 | 29 | 0.020 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.020 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.020 | |
| cellular response to fibroblast growth factor stimulus | GO:0044344 | 47 | 0.020 | |
| extraocular skeletal muscle development | GO:0002074 | 2 | 0.020 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.020 | |
| triglyceride mobilization | GO:0006642 | 5 | 0.020 | |
| microtubule based process | GO:0007017 | 236 | 0.020 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.020 | |
| tissue remodeling | GO:0048771 | 102 | 0.020 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.020 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.020 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.020 | |
| cellular response to arsenic containing substance | GO:0071243 | 4 | 0.020 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.020 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.019 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.019 | |
| regulation of calcium ion transmembrane transport | GO:1903169 | 20 | 0.019 | |
| kidney rudiment formation | GO:0072003 | 3 | 0.019 | |
| regulation of cell growth | GO:0001558 | 91 | 0.019 | |
| isoprenoid metabolic process | GO:0006720 | 29 | 0.019 | |
| glucan metabolic process | GO:0044042 | 32 | 0.019 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.019 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.019 | |
| response to temperature stimulus | GO:0009266 | 55 | 0.019 | |
| regulation of nitrogen cycle metabolic process | GO:1903314 | 1 | 0.019 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.019 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.019 | |
| gas homeostasis | GO:0033483 | 3 | 0.019 | |
| acetate ester transport | GO:1901374 | 2 | 0.019 | |
| female gonad development | GO:0008585 | 71 | 0.019 | |
| epithelial cell migration | GO:0010631 | 63 | 0.019 | |
| response to muscle stretch | GO:0035994 | 1 | 0.019 | |
| cerebellum morphogenesis | GO:0021587 | 42 | 0.019 | |
| axon guidance | GO:0007411 | 141 | 0.019 | |
| response to inorganic substance | GO:0010035 | 96 | 0.019 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.019 | |
| potassium ion transport | GO:0006813 | 52 | 0.019 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.019 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.018 | |
| nucleic acid phosphodiester bond hydrolysis | GO:0090305 | 49 | 0.018 | |
| response to light stimulus | GO:0009416 | 135 | 0.018 | |
| substantia nigra development | GO:0021762 | 2 | 0.018 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.018 | |
| trachea cartilage morphogenesis | GO:0060535 | 4 | 0.018 | |
| defense response to other organism | GO:0098542 | 197 | 0.018 | |
| white fat cell proliferation | GO:0070343 | 2 | 0.018 | |
| spermatid differentiation | GO:0048515 | 115 | 0.018 | |
| peripheral nervous system axon regeneration | GO:0014012 | 2 | 0.018 | |
| cellular glucan metabolic process | GO:0006073 | 32 | 0.018 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.018 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.018 | |
| regulation of lymphocyte apoptotic process | GO:0070228 | 41 | 0.018 | |
| hormone secretion | GO:0046879 | 128 | 0.018 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.018 | |
| potassium ion homeostasis | GO:0055075 | 4 | 0.018 | |
| negative regulation of phospholipid biosynthetic process | GO:0071072 | 1 | 0.018 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.018 | |
| female genitalia morphogenesis | GO:0048807 | 3 | 0.018 | |
| response to acid chemical | GO:0001101 | 111 | 0.018 | |
| semicircular canal fusion | GO:0060879 | 1 | 0.018 | |
| positive regulation of fibroblast proliferation | GO:0048146 | 20 | 0.018 | |
| membrane depolarization | GO:0051899 | 64 | 0.018 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.017 | |
| cerebellum formation | GO:0021588 | 1 | 0.017 | |
| forward locomotion | GO:0043056 | 1 | 0.017 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.017 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.017 | |
| germ cell development | GO:0007281 | 185 | 0.017 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.017 | |
| male genitalia morphogenesis | GO:0048808 | 4 | 0.017 | |
| lung proximal distal axis specification | GO:0061115 | 1 | 0.017 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.017 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.017 | |
| fluid transport | GO:0042044 | 14 | 0.017 | |
| regulation of long term synaptic depression | GO:1900452 | 3 | 0.017 | |
| negative regulation of cell growth | GO:0030308 | 44 | 0.017 | |
| activation of adenylate cyclase activity | GO:0007190 | 4 | 0.017 | |
| immune effector process | GO:0002252 | 321 | 0.017 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.017 | |
| positive regulation of sodium ion transmembrane transport | GO:1902307 | 4 | 0.017 | |
| peptidyl cysteine s nitrosylation | GO:0018119 | 4 | 0.017 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.017 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.017 | |
| long chain fatty acid import | GO:0044539 | 2 | 0.017 | |
| potassium ion import | GO:0010107 | 1 | 0.017 | |
| positive regulation of fatty acid metabolic process | GO:0045923 | 8 | 0.017 | |
| camera type eye development | GO:0043010 | 266 | 0.017 | |
| learning | GO:0007612 | 98 | 0.017 | |
| positive regulation of white fat cell proliferation | GO:0070352 | 1 | 0.017 | |
| steroid metabolic process | GO:0008202 | 119 | 0.017 | |
| cerebellar cortex development | GO:0021695 | 48 | 0.017 | |
| protein maturation | GO:0051604 | 176 | 0.017 | |
| cell fate commitment | GO:0045165 | 210 | 0.017 | |
| regulation of renal sodium excretion | GO:0035813 | 3 | 0.017 | |
| rna interference | GO:0016246 | 2 | 0.017 | |
